Cargando…
Publisher Correction: BIRC2–BIRC3 amplification: a potentially druggable feature of a subset of head and neck cancers in patients with Fanconi anemia
Autores principales: | Roohollahi, Khashayar, de Jong, Yvonne, Pai, Govind, Zaini, Mohamad Amr, de Lint, Klaas, Sie, Daoud, Rooimans, Martin A., Rockx, Davy, Hoskins, Elizabeth E., Ameziane, Najim, Wolthuis, Rob, Joenje, Hans, Wells, Susanne I., Dorsman, Josephine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987091/ https://www.ncbi.nlm.nih.gov/pubmed/35388046 http://dx.doi.org/10.1038/s41598-022-09471-8 |
Ejemplares similares
-
BIRC2–BIRC3 amplification: a potentially druggable feature of a subset of head and neck cancers in patients with Fanconi anemia
por: Roohollahi, Khashayar, et al.
Publicado: (2022) -
Diagnosis of Fanconi Anemia: Mutation Analysis by Next-Generation Sequencing
por: Ameziane, Najim, et al.
Publicado: (2012) -
BIRC3 and BIRC5: multi‐faceted inhibitors in cancer
por: Frazzi, Raffaele
Publicado: (2021) -
Genome-wide siRNA screens identify RBBP9 function as a potential target in Fanconi anaemia-deficient head-and-neck squamous cell carcinoma
por: Pai, Govind, et al.
Publicado: (2023) -
Differential regulation of BIRC2 and BIRC3 expression by inflammatory cytokines and glucocorticoids in pulmonary epithelial cells
por: Thorne, Andrew, et al.
Publicado: (2023)